Početna › Dijabetes tipa 2 › Nebraska
Kliničke studije za Dijabetes tipa 2 u državi Nebraska
14 studija za Dijabetes tipa 2 traži sudionike na lokacijama u državi Nebraska.
Gradovi u državi Nebraska
Službeni tekst studije (engleski)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Methodist Physicians Clinic, Fremont
- Quality Clinical Research - Omaha, Omaha
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Bryan Heart, Lincoln
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 55 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- University Of Nebraska Medical Center, Omaha
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07595549A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Omaha
- Research Site, Omaha
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Nebraska Medical Center, Omaha
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Omaha
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Lincoln, Lincoln
- Velocity Clinical Research, Omaha, Omaha
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07296484A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Omaha
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Methodist Phys. Clinic, Omaha
U tijeku regrutacijaFaza 3
Od 45 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Elkhorn
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT07662109Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Methodist Physicians Clinic, Fremont
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 17. kol 2026. · NCT07527650HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Velocity Clinical Research Norfolk, Norfolk
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 23. tra 2026. · NCT07546929Blood Markers of Early Pancreas Cancer
- Unversity of Nebraska Medical Center, Omaha
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 godina i više · Oba spola · Ažurirano 2. velj 2026. · NCT03568630SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
- University of Nebraska Medical Center, Omaha
U tijeku regrutacija
Od 19 do 89 godina · Oba spola · Ažurirano 22. lis 2025. · NCT06480786Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.